Oct. 5, 2020 — Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or drugs for main contributions to the combat towards blood-borne hepatitis.
Hepatitis C, which causes cirrhosis and liver cancer, causes 400,000 deaths worldwide annually, the Washington Publish reported.
The three recipients are: Harvey Alter, a medical scientist at a U.S. Nationwide Institutes of Well being blood financial institution; Charles Rice, of the Washington College in St. Louis; and British-born virologist Michael Houghton.
The researchers’ work was described by the Nobel Committee as “a landmark achievement in our battle towards viral infections,” the Publish reported.
